D.E. Shaw & Co’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-74,788
| Closed | -$1.33M | – | 2847 |
|
|
2018
Q3 | $1.33M | Sell |
74,788
-602,215
| -89% | -$10.7M | ﹤0.01% | 1711 |
|
|
2018
Q2 | $9.34M | Sell |
677,003
-937,556
| -58% | -$12.9M | 0.01% | 833 |
|
|
2018
Q1 | $14.7M | Sell |
1,614,559
-462,943
| -22% | -$4.21M | 0.02% | 627 |
|
|
2017
Q4 | $8.89M | Buy |
2,077,502
+1,660,361
| +398% | +$7.11M | 0.01% | 822 |
|
|
2017
Q3 | $588K | Buy |
417,141
+194,182
| +87% | +$274K | ﹤0.01% | 2005 |
|
|
2017
Q2 | $334K | Sell |
222,959
-94,435
| -30% | -$141K | ﹤0.01% | 2108 |
|
|
2017
Q1 | $816K | Sell |
317,394
-40,154
| -11% | -$103K | ﹤0.01% | 1800 |
|
|
2016
Q4 | $912K | Buy |
357,548
+25,957
| +8% | +$66.2K | ﹤0.01% | 1787 |
|
|
2016
Q3 | $1.03M | Buy |
331,591
+73,371
| +28% | +$227K | ﹤0.01% | 1695 |
|
|
2016
Q2 | $829K | Sell |
258,220
-34,514
| -12% | -$111K | ﹤0.01% | 1869 |
|
|
2016
Q1 | $907K | Buy |
292,734
+48,511
| +20% | +$150K | ﹤0.01% | 1787 |
|
|
2015
Q4 | $980K | Buy |
244,223
+131,337
| +116% | +$527K | ﹤0.01% | 1765 |
|
|
2015
Q3 | $517K | Buy |
112,886
+32,123
| +40% | +$147K | ﹤0.01% | 2023 |
|
|
2015
Q2 | $419K | Sell |
80,763
-18,078
| -18% | -$93.8K | ﹤0.01% | 2218 |
|
|
2015
Q1 | $618K | Buy |
98,841
+32,930
| +50% | +$206K | ﹤0.01% | 1988 |
|
|
2014
Q4 | $415K | Buy |
65,911
+55,011
| +505% | +$346K | ﹤0.01% | 2080 |
|
|
2014
Q3 | $66K | Buy |
+10,900
| New | +$66K | ﹤0.01% | 2299 |
|
|
2014
Q2 | – | Sell |
-36,645
| Closed | -$873K | – | 2691 |
|
|
2014
Q1 | $873K | Buy |
+36,645
| New | +$873K | ﹤0.01% | 1639 |
|